Search research articles
Contact Us
Filters
Showing results (161-170 of 185) with videos related to
Page
of 19
Sort By:
Dermatology and Therapy
|
August 27, 2025
Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response
Miguel Mansilla-Polo, Carmen García-Moronta, Pablo Fernández-Crehuet, et al.
The Australasian Journal of Dermatology
|
June 19, 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study
Miguel Mansilla-Polo, Martí Pons-Benavent, Pablo Fernández-Crehuet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 11, 2025
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study
Lía Bejarano, Mercè Grau-Pérez, Marina Paíno-Román, et al.
Journal of the American Academy of Dermatology
|
March 28, 2020
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
Esteban Daudén, Gregorio Carretero, Raquel Rivera, et al.
Acta Dermato-Venereologica
|
December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort
Carlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
Journal of the American Academy of Dermatology
|
March 12, 2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study
Ignasi Marti-Marti, Sebastian Podlipnik, Javier Cañueto, et al.
Journal of the American Academy of Dermatology
|
October 30, 2020
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
Ofelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, et al.
Nature Medicine
|
June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
Miguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
International Journal of Dermatology
|
September 30, 2025
Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors
Miguel Antonio Lasheras-Pérez, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, et al.
Acta Dermato-Venereologica
|
March 12, 2026
Cutaneous Leishmaniasis in Patients under Biologic Therapies: A Spanish CLINI-AEDV Multicentre Study
Andrea Ciudad, Ramón M Pujol, Fernándo Gallardo, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 185) with videos related to
Sort By:
Page
of 19
Dermatology and Therapy
|
August 27, 2025
Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response
Miguel Mansilla-Polo, Carmen García-Moronta, Pablo Fernández-Crehuet, et al.
The Australasian Journal of Dermatology
|
June 19, 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study
Miguel Mansilla-Polo, Martí Pons-Benavent, Pablo Fernández-Crehuet, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 11, 2025
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study
Lía Bejarano, Mercè Grau-Pérez, Marina Paíno-Román, et al.
Journal of the American Academy of Dermatology
|
March 28, 2020
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
Esteban Daudén, Gregorio Carretero, Raquel Rivera, et al.
Acta Dermato-Venereologica
|
December 3, 2020
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort
Carlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, et al.
Journal of the American Academy of Dermatology
|
March 12, 2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study
Ignasi Marti-Marti, Sebastian Podlipnik, Javier Cañueto, et al.
Journal of the American Academy of Dermatology
|
October 30, 2020
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
Ofelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, et al.
Nature Medicine
|
June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
Miguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
International Journal of Dermatology
|
September 30, 2025
Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors
Miguel Antonio Lasheras-Pérez, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, et al.
Acta Dermato-Venereologica
|
March 12, 2026
Cutaneous Leishmaniasis in Patients under Biologic Therapies: A Spanish CLINI-AEDV Multicentre Study
Andrea Ciudad, Ramón M Pujol, Fernándo Gallardo, et al.
Page
of 19